Woodcock to remain at FDA, with focus on operations

Janet Woodcock “has graciously agreed to stay on” at FDA, Commissioner Rob Califf said Thursday.

Woodcock, who shifted from acting commissioner to principal deputy commissioner when Califf was sworn in, will focus on operations, the FDA chief said at a hearing of the Senate Appropriations subcommittee on agriculture, rural development, FDA and related agencies to discuss FDA’s budget. ...